NASDAQ:LUNG
Pulmonx
- Stock
Last Close
1.81
06/11 22:07
Market Cap
246.48M
Beta: 0.32
Volume Today
1.55M
Avg: 503.90K
PE Ratio
−8.91
PFCF: −17.91
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
average inventory | 4.47M - | 8.18M 83.08% | 13.51M 65.27% | 15.42M 14.15% | 15.65M 1.48% | ||
average payables | 1.99M - | 2.08M 4.61% | 1.53M 26.46% | 1.67M 9.36% | 1.63M 2.54% | ||
average receivables | 4.66M - | 5.06M 8.66% | 5.39M 6.56% | 7.62M 41.23% | 10.39M 36.37% | ||
book value per share | -8.08 - | -9.05 11.98% | 22.20 345.39% | 5.35 75.91% | 4.15 22.38% | 0.00 99.92% | |
capex per share | -0.02 - | -0.03 127.85% | -0.09 157.27% | -0.10 13.60% | -0.04 65.03% | -0.00 99.94% | |
capex to depreciation | -1.17 - | -1.97 68.55% | -1.89 4.38% | -4.23 124.49% | -0.87 79.43% | -0.52 40.16% | |
capex to operating cash flow | 0.02 - | 0.03 101.83% | 0.03 14.23% | 0.09 198.25% | 0.03 67.04% | 0.02 26.60% | |
capex to revenue | -0.02 - | -0.02 39.83% | -0.03 25.99% | -0.08 172.44% | -0.02 67.61% | -0.01 52.16% | |
cash per share | 0.20 - | 1.37 587.37% | 22.74 1,560.97% | 4.98 78.08% | 3.80 23.65% | 0.00 99.92% | |
days of inventory on hand | 157.01 - | 201.20 28.14% | 339.99 68.99% | 464.89 36.73% | 385.29 17.12% | 340.97 11.50% | |
days payables outstanding | 60.96 - | 96.12 57.67% | 46.59 51.52% | 45.16 3.08% | 46.51 2.98% | 30.49 34.45% | |
days sales outstanding | 62.42 - | 66.05 5.81% | 47.15 28.62% | 49.47 4.93% | 59.02 19.30% | 64.34 9.01% | |
debt to assets | 2.29 - | 0.41 82.18% | 0.10 74.67% | 0.11 8.99% | 0.13 11.98% | 0.23 84.93% | |
debt to equity | -0.21 - | -0.12 43.27% | 0.12 203.41% | 0.14 13.74% | 0.16 15.72% | 0.35 120.97% | |
dividend yield | |||||||
earnings yield | -0.02 - | -0.03 12.04% | -0.05 80.29% | -0.04 8.40% | -0.19 348.64% | -0.00 99.93% | |
enterprise value | 843.55M - | 821.11M 2.66% | 498.62M 39.28% | 1.04B 107.90% | 235.39M 77.29% | 484.13B 205,573.11% | |
enterprise value over ebitda | -53.81 - | -46.50 13.58% | -17.29 62.82% | -21.83 26.25% | -4.09 81.25% | -7.82K 190,858.69% | |
ev to operating cash flow | -45.86 - | -39.54 13.77% | -16.28 58.84% | -25.05 53.88% | -5.22 79.15% | -12.87K 246,439.77% | |
ev to sales | 42.17 - | 25.19 40.26% | 15.23 39.53% | 21.41 40.56% | 4.39 79.51% | 7.05K 160,611.04% | |
free cash flow per share | -0.90 - | -1.04 14.83% | -3.10 198.53% | -1.25 59.73% | -1.25 0.29% | -0.00 99.92% | |
free cash flow yield | -0.02 - | -0.03 14.83% | -0.04 70.02% | -0.04 13.34% | -0.15 281.54% | -0.00 99.95% | |
graham net net | -8.40 - | -9.92 18.02% | 19.89 300.55% | 4.18 78.96% | 3.11 25.74% | 0.00 99.94% | |
graham number | 12.74 - | 14.27 12.01% | 39.76 178.71% | 12.73 67.98% | 12.18 4.32% | 0.01 99.91% | |
income quality | 1.00 - | 1.00 0.76% | 0.95 5.24% | 0.85 10.51% | 0.77 10.04% | 0.62 19.21% | |
intangibles to total assets | 0.20 - | 0.05 73.11% | 0.01 80.58% | 0.01 7.09% | 0.01 15.70% | 0.01 3.55% | |
interest coverage | -5.97 - | -7.70 28.89% | -10.16 32.02% | -57.06 461.40% | -55.01 3.60% | 19.16 134.84% | |
interest debt per share | 1.78 - | 1.17 34.52% | 2.99 156.20% | 0.76 74.70% | 0.69 9.11% | 0.00 99.85% | |
inventory turnover | 2.32 - | 1.81 21.96% | 1.07 40.82% | 0.79 26.87% | 0.95 20.66% | 1.07 13.00% | |
invested capital | -0.21 - | -0.12 43.27% | 0.12 203.41% | 0.14 13.74% | 0.16 15.72% | 0.35 120.97% | |
market cap | 814.07M - | 814.07M 0% | 702.96M 13.65% | 1.16B 64.83% | 312.72M 73.01% | 484.18B 154,725.33% | |
net current asset value | -171.03M - | -199.84M 16.84% | 212.41M 206.29% | 166.07M 21.82% | 129.28M 22.15% | 90.96M 29.65% | |
net debt to ebitda | -1.88 - | -0.40 78.78% | 7.09 1,875.56% | 2.57 63.74% | 1.34 47.66% | 0.68 49.43% | |
net income per share | -0.89 - | -1.00 12.04% | -3.16 216.55% | -1.35 57.44% | -1.59 17.93% | -0.00 99.90% | |
operating cash flow per share | -0.89 - | -1.00 12.89% | -3.01 199.96% | -1.15 61.91% | -1.22 6.09% | -0.00 99.92% | |
payables turnover | 5.99 - | 3.80 36.58% | 7.83 106.28% | 8.08 3.17% | 7.85 2.90% | 11.97 52.55% | |
receivables turnover | 5.85 - | 5.53 5.49% | 7.74 40.09% | 7.38 4.70% | 6.18 16.18% | 5.67 8.26% | |
research and ddevelopement to revenue | 0.35 - | 0.19 46.90% | 0.23 22.81% | 0.27 18.39% | 0.29 6.34% | 0.26 8.24% | |
return on tangible assets | -1.54 - | -0.41 73.40% | -0.12 69.77% | -0.21 69.42% | -0.31 47.29% | -0.35 12.54% | |
revenue per share | 0.97 - | 1.57 62.94% | 3.21 104.19% | 1.34 58.30% | 1.45 7.95% | 0.00 99.87% | |
roe | 0.11 - | 0.11 0.05% | -0.14 229.00% | -0.25 76.68% | -0.38 51.94% | -0.51 34.41% | |
roic | 0.11 - | 0.11 1.01% | -0.12 208.09% | -0.21 68.43% | -0.32 52.70% | -0.38 19.93% | |
sales general and administrative to revenue | 1.02 - | 1.05 3.16% | |||||
shareholders equity per share | -8.08 - | -9.05 11.98% | 22.20 345.39% | 5.35 75.91% | 4.15 22.38% | 0.00 99.92% | |
stock based compensation to revenue | 0.02 - | 0.01 38.96% | 0.10 774.59% | 0.22 122.68% | 0.31 40.91% | 0.32 5.01% | |
tangible asset value | -170.31M - | -190.24M 11.70% | 223.40M 217.43% | 190.63M 14.67% | 151.52M 20.52% | 115.95M 23.47% | |
tangible book value per share | -8.22 - | -9.19 11.70% | 21.93 338.78% | 5.28 75.95% | 4.08 22.59% | 0.00 99.93% | |
working capital | 3.24M - | 26.91M 731.58% | 237.46M 782.43% | 190.45M 19.80% | 150.46M 21.00% | 127.27M 15.42% |
All numbers in USD (except ratios and percentages)